Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Similarity of Biocon Insulin 70/30 and Humulin 70/30 in Healthy Volunteers
NCT04022291Phase 1Completed
- Sponsor
- Biocon
- Start
- Jun 2019
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Insulin human regular + insulin isophane in diabetes mellitus (DM) (2 arms), sponsored by Biocon. Primary endpoints: Area under the insulin concentration curve 0-24h, Maximum insulin concentration and 2 more. Started Jun 2019; status: completed.
02
Drugs
Insulin human regular + insulin isophane
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT04022291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022291.